Clinical Trial Update: An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy [Phase 3]

View source ↗

Summary

This Phase 3 randomized, double-blind study compared fixed-dose combinations of T80 plus A5 to A5 monotherapy in hypertension patients who did not respond adequ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• A5
• T80

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-09-20